Abstract
Stroke remains the third leading cause of death in the UK after coronary heart disease and cancer, and the main cause of adult disability in the western world (Bonita, 1992). Unfortunately, for those people who suffer a recurrent stroke, outcomes are poorer than for those after a first stroke (Lee et al, 2004). The Royal College of Physicians (2004: 40) recommend: ‘An individual strategy for stroke prevention should be implemented within a maximum of seven days of acute stroke or transcient ischaemic attack.’ This paper explores the evidence base for interventions in secondary stroke prevention. Risk factors for stroke are outlined, the role of anti-platelet therapy is discussed, and pharmacological strategies in the management of hyperglycaemia, hyperlipidaemia and hypertension are examined. The risk factor of cigarette smoking is also addressed. Collaborative goal setting and care planning is a central tenet of this case study, with the patient enabled to make informed life-style changes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
